NAT10-mediated lipid metabolic reprogramming drives EGFR-TKI resistance in non-small cell lung cancer via ac4C-dependent mRNA stabilization
link.springer.com/article/10.1186/s40164-025-...Posted Dec 1, 2025, 4:13 AM UTC
20
link.springer.com
Loading comments…